PM Stock Analysis: Philip Morris International | NYSE
Tobacco | NYSE, USA | Market Cap: 308.418m USD | 12M Return: 30.9% | US7181721090 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.01B
EPS Trend: 99.2%
Qual. Beats: 3
Rev. Trend: 99.9%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Philip Morris International Inc. (NYSE: PM) is a major U.S.-incorporated tobacco company headquartered in Stamford, Connecticut, operating in the consumer staples sector. The company offers both traditional cigarettes and a growing portfolio of smoke-free products, including heat-not-burn (IQOS), e-vapor (VEEV), and oral nicotine (ZYN) brands, alongside consumer accessories like lighters and matches.
PMI also sells wellness products and was established in 1987, with its stock debuting on the NYSE in March 2008. As a mega-cap player in the global tobacco industry, the company has been strategically shifting its revenue mix toward reduced-risk products as cigarette consumption declines in many developed markets, a transition common among large tobacco manufacturers seeking long-term growth amid tightening regulations.
- IQOS smoke-free products drive double-digit revenue growth
- ZYN nicotine pouches expand US market share rapidly
- Menthol bans and FX headwinds pressure cigarette margins
| Net Income: 10.7b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA 5.28 > 1.0 |
| NWC/Revenue: 1.37% < 20% (prev -10.14%; Δ 11.51% < -1%) |
| CFO/TA 0.23 > 3% & CFO 15.2b > Net Income 10.7b |
| Net Debt (40.9b) to EBITDA (19.3b): 2.12 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.56b) vs 12m ago 0.31% < -2% |
| Gross Margin: 67.74% > 18% (prev 66.92%; Δ 0.82% > 0.5%) |
| Asset Turnover: 64.49% > 50% (prev 59.64%; Δ 4.85% > 0%) |
| Interest Coverage Ratio: 11.34 > 6 (EBIT TTM 17.2b / Interest Expense TTM 1.52b) |
| A: 0.01 (Total Current Assets 25.8b - Total Current Liabilities 25.2b) / Total Assets 66.7b |
| B: 0.55 (Retained Earnings 36.9b / Total Assets 66.7b) |
| C: 0.26 (EBIT TTM 17.2b / Avg Total Assets 66.9b) |
| D: -0.11 (Book Value of Equity -7.94b / Total Liabilities 72.7b) |
| Altman-Z'' = 3.47 = A |
| DSRI: 1.04 (Receivables 6.53b/5.82b, Revenue 43.1b/40.0b) |
| GMI: 0.99 (GM 66.92% / 67.74%) |
| AQI: 0.90 (AQ_t 0.49 / AQ_t-1 0.54) |
| SGI: 1.08 (Revenue 43.1b / 40.0b) |
| TATA: -0.07 (NI 10.7b - CFO 15.2b) / TA 66.7b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of November 13, 2026, the stock is trading at USD 196.66 with a total of 3,338,752 shares traded. Over the past week, the price has changed by -2.40%, over one month by -2.64%, over three months by +6.53% and over the past year by +30.89%.
Current recommended Stop Loss: 189.00 (which is 3.9% or 1.4 ATR below the current price).
Philip Morris International has received a consensus analysts rating of 4.31. Therefore, it is recommended to buy PM.
- StrongBuy: 9
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 213.3 | 8.4% |
P/E Trailing = 28.8876
P/E Forward = 21.645
P/S = 7.1496
P/B = 1318.6993
P/EG = 2.6084
Revenue TTM = 43.1b USD
EBIT TTM = 17.2b USD
EBITDA TTM = 19.3b USD
Long Term Debt = 41.7b USD (from longTermDebt, last quarter)
Short Term Debt = 5.85b USD (from shortTermDebt, last quarter)
Debt = 47.6b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 40.9b USD (calculated: Debt 47.6b - CCE 6.68b)
Enterprise Value = 349b USD (308b + Debt 47.6b - CCE 6.68b)
Interest Coverage Ratio = 11.34 (Ebit TTM 17.2b / Interest Expense TTM 1.52b)
EV/FCF = 25.69x (Enterprise Value 349b / FCF TTM 13.6b)
FCF Yield = 3.89% (FCF TTM 13.6b / Enterprise Value 349b)
FCF Margin = 31.52% (FCF TTM 13.6b / Revenue TTM 43.1b)
Net Margin = 24.82% (Net Income TTM 10.7b / Revenue TTM 43.1b)
Gross Margin = 67.74% ((Revenue TTM 43.1b - Cost of Revenue TTM 13.9b) / Revenue TTM)
Gross Margin QoQ = 68.67% (prev 68.43%)
Tobins Q-Ratio = 5.23 (Enterprise Value 349b / Total Assets 66.7b)
Interest Expense / Debt = 3.19% (Interest Expense 1.52b / Debt 47.6b)
Taxrate = 21.85% (3.29b / 15.1b)
NOPAT = 13.5b (EBIT 17.2b * (1 - 21.85%))
Current Ratio = 1.02 (Total Current Assets 25.8b / Total Current Liabilities 25.2b)
Debt / Equity = -5.99 (negative equity) (Debt 47.6b / totalStockholderEquity, last quarter -7.94b)
Debt / EBITDA = 2.12 (Net Debt 40.9b / EBITDA 19.3b)
Debt / FCF = 3.01 (Net Debt 40.9b / FCF TTM 13.6b)
Total Stockholder Equity = -8.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.01% (Net Income 10.7b / Total Assets 66.7b)
RoE = -119.7% (negative equity) (Net Income TTM 10.7b / Total Stockholder Equity -8.95b)
RoCE = 52.54% (EBIT 17.2b / Capital Employed (Equity -8.95b + L.T.Debt 41.7b))
RoIC = 29.74% (NOPAT 13.5b / Invested Capital 45.2b)
WACC = 4.27% (E(308b)/V(356b) * Re(4.54%) + D(47.6b)/V(356b) * Rd(3.19%) * (1-Tc(0.22)))
Discount Rate = 4.54% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 90.98 | Cagr: 0.19%
[DCF] Terminal Value 77.97% ; FCFF base≈12.2b ; Y1≈14.0b ; Y5≈20.6b
[DCF] Fair Price = 172.6 (EV 310b - Net Debt 40.9b = Equity 269b / Shares 1.56b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.23 | EPS CAGR: 13.29% | SUE: 1.12 | # QB: 3
Revenue Correlation: 99.88 | Revenue CAGR: 7.68% | SUE: 0.47 | # QB: 0
EPS current Quarter (2027-03-31): EPS=2.05 | Chg30d=-1.61% | Revisions=-50% | Analysts=7
EPS current Year (2026-12-31): EPS=8.35 | Chg30d=-0.82% | Revisions=-67% | GrowthEPS=+10.8% | GrowthRev=+7.3%
EPS next Year (2027-12-31): EPS=9.04 | Chg30d=-1.49% | Revisions=-53% | GrowthEPS=+8.2% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: -68% (up=4, down=27)